Все категории
| Product Name | Описание | Action |
|---|---|---|
| Сацитузумаб говитекан | Trade Name : Trodelvy Target : TROP-2 Molecular Type : ADC Sales in 2025 (Millions of USD) : 1014(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Ризанкизумаб | Trade Name : Skyrizi Target : Bispecific antibody Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 13000~15000(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch ... |
|
| Тезепелумаб | Trade Name : Tezspire Target : TSLP Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 826(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Дупилумаб | Trade Name : Dupixent Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1340(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Гиалуронидаза | Trade Name : N/A Target : N/A Molecular Type : Enzymes Sales in 2025 (Millions of USD) : 1300~1375(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Etanercept, Enbrel, Erelzi, Eticovo, Анти- TNF биологический / TNF ингибитор, Фьюзионный белок, CAS No 185243-69-0 | Trade Name : Enbrel Target : N/A Molecular Type : Fusion Protein Sales in 2025 (Millions of USD) : 2300~2500(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Пертузумаб, Пержета, Фесго, 2С4, Целенаправленная терапия анти- HER2, Онкология биологические / Рак молочной железы антитела, Моноклональные антитела, CAS No.380610-27-5 | Trade Name : Perjeta Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 2800(First three quartersestimate ) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch ... |
|
| Тоцилизумаб | Trade Name : Actemra Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1280(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
